The hardship of obesity: a soft-wired hypothalamus
Clinicians should: Assess baseline HbA1c and current glycemic control before discontinuation Implement or intensify alternative therapies (metformin, SGLT2 inhibitors, or other agents) before or concurrent with tirzepatide cessation Increase home glucose monitoring frequency for several weeks post-discontinuation Schedule follow-up to evaluate metabolic stability Special consideration for insulin or sulfonylurea users : Patients taking these medications alongside tirzepatide may need proactive dose adjustments when stopping tirzepatide to prevent hypoglycemia
,
No, a liquid facelift does not require surgery
DeShields says there can be additional barriers blocking patients access, including prior authorization requirements, restrictive use criteria, and substantial out-of-pocket costs. Of these, he says, affordability remains the largest obstacle to successful implementation in everyday medical practice. What are Aetnas coverage requirements for Wegovy
Available from: Kettner J, Donnelly E, Maes ML
